The Board of Directors of Earum Pharmaceuticals Ltd, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹10.6233 crore, against ₹9.9169 crore in the corresponding quarter of the previous year (YoY) and ₹3.0701 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹5.3997 crore, against ₹-0.9870 crore in the corresponding quarter of the previous year (YoY) and ₹-3.4130 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹4.38, against ₹-1.60 in the corresponding quarter of the previous year (YoY) and ₹-5.53 in previous quarter (QoQ).
Total Income | ₹10.6233 crs | ₹3.0701 crs | 246.02% | ₹9.9169 crs | 7.12% |
Net Profit | ₹5.3997 crs | ₹-3.4130 crs | 258.21% | ₹-0.9870 crs | 647.08 % |
EPS | ₹4.38 | ₹-5.53 | 179.20% | ₹-1.60 | 373.75% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹13.6934 crore, against ₹41.8384 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹1.9867 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹-1.6271 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹1.56 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹-2.64 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹13.6934 crs | ₹41.8384 crs | -67.27% |
Net Profit | ₹1.9867 crs | ₹-1.6271 crs | 222.10% |
EPS | ₹1.56 | ₹-2.64 | 159.09% |
Shares of Earum Pharmaceuticals Ltd was last trading in BSE at Rs. 77.80 as compared to the previous close of Rs. 74.10. The total number of shares traded during the day was 44534 in over 153 trades.
The stock hit an intraday high of Rs. 77.80 and intraday low of 76.15. The net turnover during the day was Rs. 3454643.00.
Source : Equity Bulls
Keywords
EarumPharmaceuticals
Q2FY22
H1FY22
ResultUpdate